Magovcevic Ivana's most recent trade in Vigil Neuroscience Inc was a trade of 485,000 Stock Option Award (Right to Buy) done . Disclosure was reported to the exchange on March 3, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 485,000 | 485,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Ivana Magovcevic | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 19 Dec 2024 | 5,000 | 222,687 | - | 1.7 | 8,400 | Common Stock |
| Vigil Neuroscience Inc | Ivana Magovcevic | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.67 per share. | 18 Dec 2024 | 5,000 | 217,687 | - | 1.7 | 8,350 | Common Stock |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.34 per share. | 05 Dec 2024 | 5,000 | 212,687 | - | 2.3 | 11,700 | Common Stock |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 370,000 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 370,000 | 370,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 May 2024 | 282,000 | 282,000 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 03 May 2024 | 282,000 | 0 | - | - | Stock Option Award (Right to Buy) | |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 463,000 | 463,000 | - | - | Stock Option Grant (Right to Buy) | |
| Aeglea BioTherapeutics Inc | Magovcevic Ivana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 1,950,000 | 1,950,000 | - | - | Stock Option (right to buy) | |
| Vigil Neuroscience Inc | Magovcevic Ivana | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 370,000 | 370,000 | - | - | Stock Option Grant (Right to Buy) | |
| Aeglea BioTherapeutics Inc | Magovcevic Ivana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 43,000 | 43,000 | - | - | Director Stock Option (right to buy) | |
| Aeglea BioTherapeutics Inc | Magovcevic Ivana | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2021 | 40,000 | 40,000 | - | - | Director Stock Option (right to buy) |